Health Condition 1: K519- Ulcerative colitis, unspecified
Conditions
Interventions
None listed
Sponsors
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Only the patients with positive colonoscopic finding of ulcerative colitis will be included in the present clinical study. 2.History of passing of bloody stool or diarrhea mixed with blood and mucus. 3.Bleed on rectal examination. 4.Abdominal pain. 5.Increase of abdominal sound. 6.Malnutrition. 7.Weight loss. 8.Participants should have signed informed consent letter.
Exclusion criteria
Exclusion criteria: 1.Pregnant or planning for pregnancy, breastfeeding mother 2.Enrolled in other clinical trials 3.Have active malignancy or are under investigation for malignancy Have a history of any of the following medical conditions- Cushing syndrome, HIV, Chronic kidney disease(CKD), Chronic liver disease(CLD),Hematemesis Currently taking any of the following medication- Alcohol or drug abuse, psychiatric medication, oral steroid.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be measured based on clinical outcome, colonoscopic outcome, Hematological and biochemical outcome, fecalysis outcome measures including OBT to determine the effectiveness and safety of the test drug for the Treatment of Ulcerative colitis(Pittaja Atisara).Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The Effect of the test drug medication alters the quality of the life that will be evaluated after completion of the treatment.Timepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactJalal Miah
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
Outcome results
None listed